[Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
D000328:Adult; D000368:Aged; D001729:Bismuth; D002167:Campylobacter / Q000187:drug effects; D002169:Campylobacter Infections / Q000188:drug therapy*; D002927:Cimetidine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011897:Random Allocation; D012008:Recurrence; D012459:Salicylates / Q000627:therapeutic use*; D013276:Stomach Ulcer / Q000188:drug therapy*; D014945:Wound Healing
D009942:Organometallic Compounds; D012459:Salicylates; C015715:bismuth subsalicylate; D002927:Cimetidine; D001729:Bismuth
Wirkung von Wismutsubsalicylat versus Cimetidin auf Campylobacter pylori, Ulkusheilung und -rezidivrate.